These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9302347)

  • 1. Differential effects of d-sotalol on normal and infarcted myocardium: an experimental study using epicardial mapping.
    Freigang KD; Bauer A; Becker R; Senges JC; Kraft P; Brachmann J; Kübler W; Schoels W
    Cardiovasc Res; 1997 Jul; 35(1):52-9. PubMed ID: 9302347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis.
    Cabo C; Boyden PA
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H372-84. PubMed ID: 12388240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
    Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Kraft P; Kuebler W; Schoels W
    Basic Res Cardiol; 2000 Aug; 95(4):324-32. PubMed ID: 11005588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of delayed ventricular repolarization to the anti-arrhythmic efficacy of sotalol.
    Brachmann J; Senges J; Lengfelder W; Jauernig R; Rizos I; Czygan E; Cobbe SM; Kübler W
    Eur Heart J; 1985 Nov; 6 Suppl D():171-4. PubMed ID: 3936715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment.
    Chinushi M; Tagawa M; Kasai H; Washizuka T; Abe A; Furushima H; Aizawa Y
    Jpn Circ J; 2001 Aug; 65(8):702-6. PubMed ID: 11502045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-repolarization refractoriness increases vulnerability to block and initiation of reentrant impulses in heterogeneous infarcted myocardium.
    Cabo C
    Comput Biol Med; 2015 Oct; 65():209-19. PubMed ID: 25987316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
    Kassotis J; Sauberman RB; Cabo C; Wit AL; Coromilas J
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction.
    Takatsuki S; Mitamura H; Sueyoshi K; Kanki H; Furuno I; Ogawa S
    Jpn Heart J; 1998 Sep; 39(5):687-97. PubMed ID: 9926000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Circulation; 1983 Oct; 68(4):865-71. PubMed ID: 6616781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Popova EP
    Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms.
    Miyazaki T; Ogawa S; Sakai T; Hosokawa M; Sakurai K; Nakamura Y
    Jpn Circ J; 1988 Mar; 52(3):254-61. PubMed ID: 3373717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R; Garrison GL; Berlin KD
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple in vivo model to evaluate the effects of antiarrhythmic agents.
    Solomon AJ; Syn D; Barbey JT
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2092-6. PubMed ID: 1279605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
    Aidonidis I; Rizos I; Hilbel T; Kuebler W; Brachmann J
    J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flecainide and D-sotalol on myocardial conduction and refractoriness: relation to antiarrhythmic and proarrhythmic drug effects.
    Kidwell GA; Gonzalez MD
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):621-32. PubMed ID: 7681909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium.
    Schmitt C; Beyer T; Karch M; Montero M; Hilbel T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):487-92. PubMed ID: 1380589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
    Lynch JJ; Coskey LA; Montgomery DG; Lucchesi BR
    Am Heart J; 1985 May; 109(5 Pt 1):949-58. PubMed ID: 3993529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of left ventricular systolic pressure increase on ventricular arrhythmogenicity in old canine myocardial infarction.
    Yano K; Hano O; Hirata T; Matsumoto Y; Hirata M; Mitsuoka T
    Cardiovasc Res; 1992 Oct; 26(10):988-93. PubMed ID: 1486594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispersion of ventricular refractoriness in experimental myocardial infarction: effect of sotalol.
    Lubiński A; Hindricks G; Shenasa M; Haverkamp W; Vogt B; Borggrefe M; Breithardt G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2090-4. PubMed ID: 7845823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.